Ignite Creation Date:
2025-12-24 @ 6:55 PM
Ignite Modification Date:
2026-01-27 @ 10:43 AM
Study NCT ID:
NCT00024557
Status:
COMPLETED
Last Update Posted:
2011-06-06
First Post:
2001-09-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
Sponsor:
INSYS Therapeutics Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IL13PEI-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None